Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rao, P.
Right arrow Articles by García-Ocaña, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rao, P.
Right arrow Articles by García-Ocaña, A.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes 54:1664-1675, 2005
© 2005 by the American Diabetes Association, Inc.

Gene Transfer of Constitutively Active Akt Markedly Improves Human Islet Transplant Outcomes in Diabetic Severe Combined Immunodeficient Mice

Poornima Rao1, Jennifer Roccisana1, Karen K. Takane1, Rita Bottino2, Allan Zhao3, Massimo Trucco2, and Adolfo García-Ocaña1

1 Division of Endocrinology and Metabolism, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania
2 Division of Immunogenetics, Department of Pediatrics, Children’s Hospital of Pittsburgh, Rangos Research Center, Pittsburgh, Pennsylvania
3 Department of Cell Biology and Physiology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania

Akt is an important intracellular mediator of ß-cell growth and survival in rodents. However, whether constitutive activation of Akt in human ß-cells enhances the survival and function of transplanted islets is unknown. In the current study, we examined the efficacy of constitutive activation of Akt in improving human islet transplant outcomes using a marginal mass model in diabetic severe combined immunodeficient (SCID) mice. Human islets transduced with adenoviruses encoding constitutively active Akt1 (Adv-CA-Akt) displayed increased total and phosphorylated Akt and Akt kinase activity compared with control islets. Expression of CA-Akt in human islets induced a significant increase in ß-cell replication and a significant decrease in ß-cell death induced by serum and glucose deprivation or chronic hyperglycemia. Two control groups of islets (1,500 uninfected or adenovirus LacZ [Adv-LacZ]–transduced human islet equivalents [IEQs]) transplanted under the kidney capsule of streptozotocin-induced diabetic SCID mice were insufficient to correct hyperglycemia. Importantly and in marked contrast to these controls, 1,500 Adv-CA-Akt–transduced IEQs were capable of restoring euglycemia in diabetic SCID mice. Moreover, blood glucose normalization persisted for at least 6 months. Human plasma insulin at day 54 after transplant was 10-fold higher in Adv-CA-Akt islet recipients (2.4 ± 0.4 ng/ml) compared with those receiving Adv-LacZ islets (0.25 ± 0.08 ng/ml) (P < 0.05). In summary, expression of CA-Akt in human islets improves islet transplant outcomes in a subcapsular renal graft model in SCID mice. Akt is an attractive target for future strategies aimed at reducing the number of islets required for successful islet transplantation in humans.


Address correspondence and reprint requests to Adolfo Garcia-Ocaña, PhD, Division of Endocrinology, BST-E-1140, University of Pittsburgh, 200 Lothrop St., Pittsburgh, PA 15261. E-mail: ocana{at}msx.dept-med.pitt.edu

Abbreviations: Adv-CA-Akt; adenovirus encoding constitutively active Akt1; Adv-LacZ, adenovirus LacZ; BrdU, bromodeoxyuridine; CK-19, cytokeratin-19; FBS, fetal bovine serum; GIP, glucose-dependent insulinotropic polypeptide; GLP-1, glucagon-like peptide-1; GSIS, glucose-stimulated insulin secretion; GSK, glycogen synthase kinase; HGF, hepatocyte growth factor; IEQ, islet equivalent; IPGTT, intraperitoneal glucose tolerance test; MOI, multiplicity of infection; PI3K, phosphatidylinositol 3'-kinase; STZ, streptozotocin; TRITC, tetramethylrhodamine isothiocyanate; TUNEL, terminal deoxynucleotidyltransferase-mediated dUTP nick end-labeling


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
DiabetesHome page
N. M. Fiaschi-Taesch, D. M. Berman, B. M. Sicari, K. K. Takane, A. Garcia-Ocana, C. Ricordi, N. S. Kenyon, and A. F. Stewart
Hepatocyte Growth Factor Enhances Engraftment and Function of Nonhuman Primate Islets
Diabetes, October 1, 2008; 57(10): 2745 - 2754.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
R. C. Vasavada, L. Wang, Y. Fujinaka, K. K. Takane, T. C. Rosa, J. M.D. Mellado-Gil, P. A. Friedman, and A. Garcia-Ocana
Protein Kinase C-{zeta} Activation Markedly Enhances {beta}-Cell Proliferation: An Essential Role in Growth Factor Mediated {beta}-Cell Mitogenesis
Diabetes, November 1, 2007; 56(11): 2732 - 2743.
[Abstract] [Full Text] [PDF]


Home page
J Mol EndocrinolHome page
R. Takahashi, H. Ishihara, K. Takahashi, A. Tamura, S. Yamaguchi, T. Yamada, H. Katagiri, and Y. Oka
Efficient and controlled gene expression in mouse pancreatic islets by arterial delivery of tetracycline-inducible adenoviral vectors
J. Mol. Endocrinol., January 1, 2007; 38(1): 127 - 136.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2005 by the American Diabetes Association.